title: Novel transcatheter closure of an iatrogenic perimembranous ventricular septal defect.
abstract: Iatrogenic membranous ventricular septal defects (VSD) are rare complications of cardiothoracic surgery, most commonly seen as a complication of aortic valve replacements. An iatrogenic VSD can lead to right sided heart failure, systemic hypoxia, and arrhythmias, and closure is often necessary. Given the increased mortality associated with repeat surgical procedures, percutaneous transcatheter closure of these iatrogenic VSDs has increasingly become the preferred choice of therapy. We describe the first case of iatrogenic membranous VSD in the setting of mitral valve replacement and tricuspid valve repair, using the newly approved Amplatzer Duct Occluder II Device from an entirely retrograde approach. © 2014 Wiley Periodicals, Inc.
authors.affiliation: Section of Cardiology, Department of Medicine, The University of Chicago, Chicago, Illinois.
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Retzer
authors.forename: Karin E
authors.initials: KE
authors.lastname: Dill
authors.forename: Atman P
authors.initials: AP
authors.lastname: Shah
mesh_terms: D000368:Aged; D006328:Cardiac Catheterization / Q000295:instrumentation; D018618:Echocardiography, Doppler, Color; D006335:Heart Injuries / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects*; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D011474:Prosthesis Design; D055989:Septal Occluder Device; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D054088:Ventricular Septum / Q000293:injuries*
keywords: VSD; closure; interventional devices/innovation; structural heart disease intervention